Md et al., 1999 - Google Patents
Natural emergence of an anti-hepatitis B s escape mutant in a young female hepatitis B virus carrier.Md et al., 1999
- Document ID
- 8594403030421768027
- Author
- Md K
- et al.
- Publication year
- Publication venue
- Pediatrics international
External Links
Snippet
Natural emergence of an anti-hepatitis B s escape mutant in a young female hepatitis B virus
carrier Page 1 Mutations altering the amino acid sequence of the ‘a’ determinant of the S region
of the hepatitis B virus (HBV) genome abolish expression of determinant ‘a’ and the resultant …
- 208000002672 hepatitis B 0 title abstract description 23
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hou et al. | A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers | |
Takahashi et al. | Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates | |
Cooreman et al. | Vaccine-and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen | |
Okamoto et al. | Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen | |
Avellon et al. | Frequency of hepatitis B virus ‘a’determinant variants in unselected Spanish chronic carriers | |
Gerlich | Medical virology of hepatitis B: how it began and where we are now | |
Ogata et al. | The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees | |
Ogata et al. | Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus | |
Blum | Hepatitis B virus: significance of naturally occurring mutants | |
Kosaka et al. | Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen | |
Kreutz | Molecular, immunological and clinical properties of mutated hepatitis B viruses | |
Kato et al. | A molecular analysis of viral persistence in surface antigen‐negative chronic hepatitis B | |
Gerner et al. | The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children | |
KR100370341B1 (en) | Hepatitis B Vaccine | |
Miyakawa et al. | The molecular basis of hepatitis B e antigen (HBeAg)‐negative infections | |
Seddigh‐Tonekaboni et al. | Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon‐treated patient | |
EP1297109B1 (en) | Hepatitis b virus dna polymerase and surface antigen variants and methods of using same | |
Melegari et al. | Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc | |
Paterlini et al. | The detection of hepatitis B virus (HBV) in HBsAG negative individuals with primary liver cancer | |
Harrison et al. | Variant hepatitis B and D viruses | |
Weber | The diagnostic and clinical impact of the genetic variability of the S (surface) gene of hepatitis B virus/Diagnostische und klinische Relevanz der genetischen Variabilität des S-(surface) Gens des Hepatitis B Virus | |
Md | Natural emergence of an anti-hepatitis B s escape mutant in a young female hepatitis B virus carrier. | |
Chan | Changing scene in hepatitis B serology interpretation | |
Uchida | Genetic variations of the hepatitis B virus and their clinical relevance | |
Kidd‐Ljunggren et al. | Hepatitis B virus strains in Thailand: genomic variants in chronic carriers |